← Leaderboards
Mylisa Parette
Keystone Nano, Inc.
$1,052,113
Attributed
$1,580,834
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.3M · FY2009–15$2M$1.5M$1M$500K$0
'09
'10
'11
'12
'13
'14
'15
Funding mix
By agency
NIH$1,580,834 · 4
By mechanism
R44$1,057,443 · 1
N43$423,391 · 2
R43$100,000 · 1
Top collaborators
- Edward A Sausville1 shared
Most similar at Keystone Nano, Inc.
Same institution · by research overlap
- Jeff A Davidson$473,423
- Yixing Jiang$473,423
- Bernadette McMahon Adair$1,999,256
Others in their field
Top investigators on “Diagnosis”
- David Heimbrook · Leidos Biomedical Research, Inc.$590,717,255
- Bambra Strokes · Ppd Development Lp$526,656,217
- Leonard Freedman · Leidos Biomedical Research, Inc.$337,858,596
- Richard K. Wilson · Washington University$297,645,172
- Sharon A Nachman · Johns Hopkins University$212,395,175
- Carol Nesel · Westat$188,148,170
Research focus
DiagnosisIn VitroNanoMalignant NeoplasmsIn VivoMalignant Breast NeoplasmLiposomesMarketingFda ApprovedCalcium PhosphateLifeBiodistributionEvaluationBiologyBreast Cancer TreatmentDrug FormulationsCellsDoseCancer TherapyBaseEngineeringIntravenousCancerousLead
Grant awards (4)
Clinical Investigation of the Ceramide NanoLiposome for Advanced Solid Tumors$1,057,443
R44 · FY2015 · CA · contact PI
DEVELOPMENT OF SIRNA NANOJACKETS FOR INFLUENZA TREATMENT$224,881
N43 · FY2015 · AI · contact PI
TAS::75 0849::TAS MULTIFUNCTIONAL NANOJACKETS FOR BREAST CANCER TREATMENT$198,510
N43 · FY2010 · CA · contact PI
Targeting NanoJacketed Doxorubicin to Tumor Sites for Improved Treatment of Breas$100,000
R43 · FY2009 · CA · contact PI